Sevion Therapeutics's ticker is and the CUSIP is 81834Q104. A total of 1 filers reported holding Sevion Therapeutics in Q4 2014. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $4,000 | -20.0% | 20,000 | 0.0% | 0.00% | 0.0% |
| Q1 2016 | $5,000 | -37.5% | 20,000 | 0.0% | 0.00% | -50.0% |
| Q4 2015 | $8,000 | -33.3% | 20,000 | 0.0% | 0.00% | 0.0% |
| Q3 2015 | $12,000 | -36.8% | 20,000 | 0.0% | 0.00% | 0.0% |
| Q2 2015 | $19,000 | +46.2% | 20,000 | 0.0% | 0.00% | 0.0% |
| Q1 2015 | $13,000 | -18.8% | 20,000 | 0.0% | 0.00% | 0.0% |
| Q4 2014 | $16,000 | -52.9% | 20,000 | -5.2% | 0.00% | -50.0% |
| Q3 2014 | $34,000 | – | 21,089 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MATRIX ASSET ADVISORS INC/NY | 20,000 | $16,000 | 0.00% |